Arthur Garson, Jr, MD, MPH, and Patrick White share final insights about where the cardiovascular community is and where it is heading with regard to managing patients through transitions between healthcare settings.
Dr Garson comments that although overall patient care has improved tremendously, hospital readmission rates continue to pose a challenge. He suggests that healthcare professionals need to personalize care when helping their patients navigate through transitions of care.
Mr White adds that the cardiovascular community needs to better manage several components that play a role in transition-of-care scenarios. He notes that while focusing on a physician’s practice is important, all other parties involved in a patient’s care should also be managed. Mr White says that partnerships with physician executives and insurance companies will be important when designing more efficient programs for patients, payers, physicians, and hospitals.
VBID, Heading Into a Third Decade, Looks to Promote Personalization and Access
March 12th 2025Speakers at the 2025 Value-Based Insurance Design summit recapped the accomplishments made over the past 20 years in designing insurance benefits with value in mind and looked ahead to iterations to come.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Closing the Gaps in Cardiac Care With Technology, Collaboration
March 12th 2025Cardiologists, primary care physicians, and value-based care leaders convened in Phoenix, Arizona, on November 12, 2024, to share case studies and insights on how to align cardiology with the principles of value-based care, including through the application of digital tools.
Read More
Reviving the Classics: The Role of Older Medications in Modern Dermatology
March 9th 2025Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost barriers.
Read More